✦ LIBER ✦

Phase II study of all-trans-retinoic acid and α-interferon in patients with advanced non-small cell lung cancer

Book ID: 122996248
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 138 KB
Volume: 14
Category: Article
ISSN: 0169-5002
DOI: 10.1016/0169-5002(96)85914-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of recombinant beta inter

Phase II study of recombinant beta interferon in patients with advanced non-small-cell lung carcinoma

✍ Ettinger, David S. ;Harwood, Kerry 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB

Eighteen patients with advanced non-smallcell lung cancer (NSCLC) received recombinant beta interferon, 90 million units three times weekly. No complete or partial responses were seen. Five patients had stable disease for several months. Most patients experienced some toxicity, most commonly fever a

Case-control study of the metabolism of

Case-control study of the metabolism of all-trans retinoic acid in non-small cell lung cancer

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Phase II study of gemcitabine and carbop

Phase II study of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer

✍ Lin Run Wang; Ming Zhu Huang; Guo Bing Zhang; Nong Xu; Xiu Hua Wu 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 385 KB

A phase II study of ifosfamide and a2b-i

A phase II study of ifosfamide and a2b-interferon in advanced non-small-cell lung cancer

✍ M. J. Lind; S. Gomm; A. P. Simmonds; L. Ashcroft; A. Kamthan; H. Gurney; N. That 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 295 KB

Phase II Study of Troxacitabine (BCH-455

Phase II Study of Troxacitabine (BCH-4556) in Patients with Advanced Non-Small-Cell Lung Cancer

✍ S.F. Dent; A. Arnold; D.J. Stewart; S. Gertler; J. Ayoub; G. Batist; G. Goss; A. 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 76 KB

55LBA Randomized phase II trial: Effect

55LBA Randomized phase II trial: Effect of all-trans retinoic acid with chemotherapy based in paclitaxel and cisplatin as first line treatment of patients with advanced non-small cell lung cancer

✍ D. Pachuca; O. Arrieta; L. Martinez; G. Villanueva; E. Arechaga; H. González-De 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB